What is RNA and how can we use the body's own RNA editing machinery to treat disease? Learn more about the Axiomer® RNA editing technology and how we are creating a new class of medicines.
… Email alerts Receive an email notification whenever ProQR issues a new press release. Never miss an important … Subscribe for email alerts Get an email alert every time ProQR issues a press release. Never miss a quarterly report, …
… Shareholder meetings archive ProQR Therapeutics - Shareholder meeting documents archive … pdf , 177.11 Ko Download link Demerger proposal ProQR Therapeutics N.V..pdf pdf , 97.37 Ko Download link …
Bart Klein was at the forefront of ProQR's Axiomer® RNA editing technology development. This platform technology makes it possible to use the cells own machinery to reverse mutations that cause a genetic disease. Read the interview.
… publication. Please read our latest community news update: ProQR agreement with Laboratoires Théa for sepofarsen and … Biasutto, born and raised in Venezuela and now heading ProQR’s LCA research and development team in Leiden (The …
ProQR recognizes the importance of advancing diversity, equity, and inclusivity (DEI) in the workplace to inspire each employee to fully thrive and to make their maximum contribution to ProQR.
On behalf of all ProQRians, happy Rare Disease Day 2022. Both within ProQR and outside, we join the community in raising awareness and trying to generate change for people worldwide living with a rare disease, their families, and supporters.
ProQR will host a virtual Analyst and Investor Event on Wednesday, December 11, 2024 from 10:00 am until approximately 12:30 pm EST, including an Analyst Q&A session with members of the ProQR Management Team.
